Literature DB >> 15642761

Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer.

Kan Kikuchi1, Amy D McDonald, Tetsuo Sasano, J Kevin Donahue.   

Abstract

BACKGROUND: Safe and effective myocardial gene transfer remains elusive. Heterogeneous ventricular gene delivery has been achieved in small mammals but generally with methods not readily transferable to the clinic. Atrium-specific gene transfer has not yet been reported. We hypothesized that homogeneous atrial gene transfer could be achieved by direct application of adenoviral vectors to the epicardial surface, use of poloxamer gel to increase virus contact time, and mild trypsinization to increase virus penetration. METHODS AND
RESULTS: We "painted" recombinant adenovirus encoding the reporter gene Escherichia coli beta-galactosidase directly onto porcine atria. Investigational variables included poloxamer use, trypsin concentration, and safety. Using the painting method, we modified the atrial phenotype with an adenovirus expressing HERG-G628S, a long-QT-syndrome mutant. Our results showed that application of virus with poloxamer alone resulted in diffuse epicardial gene transfer with negligible penetration into the myocardium. Dilute trypsin concentrations allowed complete transmural gene transfer. After trypsin exposure, echocardiographic left atrial diameter did not change. Left atrial function decreased on postoperative day 3 but returned to baseline by day 7. Tissue tensile strength was affected only in the 1% trypsin group. HERG-G628S gene transfer prolonged atrial action potential duration and refractory period without affecting ventricular electrophysiology.
CONCLUSIONS: We show complete transmural atrial gene transfer by this novel painting method. Adaptation of the method could allow application to other tissue targets. Use with functional proteins in the atria could cure or even prevent diseases such as atrial fibrillation or sinus node dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642761     DOI: 10.1161/01.CIR.0000153338.47507.83

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  51 in total

Review 1.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

2.  MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts.

Authors:  Padmini Sirish; Javier E López; Ning Li; Andrew Wong; Valeriy Timofeyev; J Nilas Young; Maryam Majdi; Ronald A Li; Huei-Sheng Vincent Chen; Nipavan Chiamvimonvat
Journal:  J Mol Cell Cardiol       Date:  2011-10-20       Impact factor: 5.000

Review 3.  [New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers].

Authors:  M Hammwöhner; A D'Alessandro; D Dobrev; P Kirchhof; A Goette
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006-06

Review 4.  Gene therapy to create biological pacemakers.

Authors:  Gerard J J Boink; Jurgen Seppen; Jacques M T de Bakker; Hanno L Tan
Journal:  Med Biol Eng Comput       Date:  2006-10-18       Impact factor: 2.602

5.  Heme oxygenase-1 induction enhances cell survival and restores contractility to unvascularized three-dimensional adult cardiomyocyte grafts implanted in vivo.

Authors:  Shunsuke Kawamoto; Jerald P Flynn; Qun Shi; Sana W Sakr; Jun Luo; Margaret D Allen
Journal:  Tissue Eng Part A       Date:  2011-03-23       Impact factor: 3.845

6.  Selective molecular potassium channel blockade prevents atrial fibrillation.

Authors:  Guy Amit; Kan Kikuchi; Ian D Greener; Lizhu Yang; Victor Novack; J Kevin Donahue
Journal:  Circulation       Date:  2010-05-17       Impact factor: 29.690

Review 7.  Reprogramming the conduction system: Onward toward a biological pacemaker.

Authors:  Jason D Meyers; Patrick Y Jay; Stacey Rentschler
Journal:  Trends Cardiovasc Med       Date:  2015-04-01       Impact factor: 6.677

8.  Biological surgery: synergetic angiogenic therapy using coadministration of two progenitor cell populations.

Authors:  Wei Li; Roy L Silverstein
Journal:  Circ Res       Date:  2008-09-26       Impact factor: 17.367

Review 9.  Human Cardiac Gene Therapy.

Authors:  Kiyotake Ishikawa; Thomas Weber; Roger J Hajjar
Journal:  Circ Res       Date:  2018-08-17       Impact factor: 17.367

Review 10.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.